Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Alvogen is recalling Fentanyl Transdermal Systems because a customer reported a carton labeled 12 mcg/h contained 50 mcg/h patches.
Zydus Pharmaceuticals is recalling Carvedilol 6.25 mg tablets because one bottle was found labeled as Acyclovir 400 mg.
Par Pharmaceutical is recalling Mycophenolate Mofetil for Injection due to the presence of particulate matter and a glass fragment in one vial.
Zydus Pharmaceuticals is recalling Acyclovir 400 mg tablets because one bottle was found to contain Carvedilol 6.25 mg tablets due to a label mix-up.
Sagent Pharmaceuticals is recalling 75,825 vials of Ketorolac Tromethamine Injection because microbial growth was detected during a routine manufacturing simulation.
Torrent Pharma Inc. is recalling Losartan Potassium Tablets, 100 mg, because FDA labs confirmed the presence of the impurity NMBA above acceptable levels.
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets 50 mg due to trace amounts of the impurity NMBA found in the active ingredient.
Customceutical Compounding is recalling Trimix HIGH injectable vials because the company cannot ensure the product is sterile. The recall covers 3 vials distributed nationwide.
Customceutical Compounding is recalling 19 vials of BPlex injectable compound due to a lack of assurance of sterility. The product was distributed nationwide.
Torrent Pharma Inc. is recalling Losartan Potassium and Hydrochlorothiazide Tablets because FDA labs found an impurity above acceptable levels.
Torrent Pharma Inc. is recalling Losartan Potassium and Hydrochlorothiazide Tablets because FDA labs found an impurity above acceptable levels.
RemedyRepack is recalling Losartan Potassium/HCTZ tablets because FDA testing found a nitrosamine impurity above acceptable levels.
Customceutical Compounding is recalling Test PROCYP injectable vials because the company cannot guarantee the product is sterile.
Customceutical Compounding is recalling 12 vials of compounded HCG injection due to a lack of assurance of sterility. The product was distributed nationwide.
Torrent Pharma Inc. is recalling Losartan Potassium Tablets, 50 mg, because FDA testing found an impurity above acceptable levels.
Torrent Pharma Inc. is recalling Losartan Potassium and Hydrochlorothiazide Tablets because FDA labs found an impurity above acceptable levels.
Customceutical Compounding is recalling TriMix MEDIUM injectable compound due to a lack of assurance of sterility. The product was distributed nationwide.
AvKARE Inc. is recalling Losartan Potassium Tablets 50 mg because FDA testing found an impurity above acceptable levels.
AvKARE Inc. is recalling Losartan Potassium Tablets 25 mg because FDA testing found an impurity above acceptable levels.
Torrent Pharma Inc. is recalling Losartan Potassium Tablets because FDA labs found an impurity above acceptable levels.
Customceutical Compounding is recalling Test D vials because the manufacturer cannot ensure the injectable solution is sterile.
Customceutical Compounding is recalling 32 vials of BPlex injectable compound because the product lacks assurance of sterility. The recall covers products distributed nationwide.
Customceutical Compounding is recalling 8 vials of Test D compounded injectable due to a lack of assurance of sterility. The product was distributed nationwide.
Customceutical Compounding is recalling 16 vials of Lipoplex injectable compound because the sterility of the product cannot be assured.
Customceutical Compounding is recalling specific lots of compounded Glutathione 200mg/mL injection vials because the FDA could not ensure the products were sterile.